Drugs / Hepatocyte Transplantation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00805610 | Jun 2014 → Jun 2016 | liver failure | Virginia Commonwealth University | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hepatocyte Transplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00805610 ↗ |
| Modality | Cell therapy | “Cell transplant may also act as a 'bridge' to whole organ transplant” NCT00805610 ↗ |
| Route | Other | “prepared hepatocytes from a single donor will be transplanted into the liver via intraportal or intrasplenic routes.” NCT00805610 ↗ |